Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Ohio 45229-3039, USA.
Innate Immun. 2010 Jun;16(3):138-42. doi: 10.1177/1753425910366879. Epub 2010 Mar 29.
The study of pulmonary surfactant, directed towards prevention and treatment of respiratory distress syndrome in preterm infants, led to the identification of novel proteins/genes that determine the synthesis, packaging, secretion, function, and catabolism of alveolar surfactant. The surfactant proteins, SP-A, SP-B, SP-C, and SP-D, and the surfactant lipid associated transporter, ABCA3, play critical roles in surfactant homeostasis. The study of their structure and function provided insight into a system that integrates the biophysical need to reduce surface tension in the alveoli and the innate host defenses required to maintain pulmonary structure and function after birth. Alveolar homeostasis depends on the intrinsic, multifunctional structures of the surfactant-associated proteins and the shared transcriptional regulatory modules that determine both the expression of genes involved in surfactant production as well as those critical for host defense. Identification of the surfactant proteins and the elucidation of the genetic networks regulating alveolar homeostasis have provided the basis for understanding and diagnosing rare and common pulmonary disorders, including respiratory distress syndrome, inherited disorders of surfactant homeostasis, and pulmonary alveolar proteinosis.
对肺表面活性剂的研究旨在预防和治疗早产儿呼吸窘迫综合征,这导致了确定新型蛋白质/基因的鉴定,这些蛋白质/基因决定了肺泡表面活性剂的合成、包装、分泌、功能和分解代谢。表面活性剂蛋白 SP-A、SP-B、SP-C 和 SP-D 以及与表面活性剂脂质相关的转运蛋白 ABCA3 在表面活性剂动态平衡中发挥着关键作用。对其结构和功能的研究提供了对一个系统的深入了解,该系统整合了肺泡中降低表面张力的生物物理需求以及出生后维持肺结构和功能所需的固有宿主防御。肺泡动态平衡取决于表面活性剂相关蛋白的内在多功能结构以及共同的转录调控模块,这些模块决定了参与表面活性剂产生的基因以及对宿主防御至关重要的基因的表达。表面活性剂蛋白的鉴定以及调节肺泡动态平衡的遗传网络的阐明为理解和诊断罕见和常见的肺部疾病提供了基础,包括呼吸窘迫综合征、表面活性剂动态平衡的遗传性疾病和肺泡蛋白沉积症。